Tower Research Capital (TRC)’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Tower Research Capital (TRC)’s Portfolio SYRA Stock Details SYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,344	Closed	-$1.65K	–	5672
2025 Q1	$1.65K	Buy	6,344 +11	+0.2%	+$5	﹤0.01%	4676
2024 Q4	$2.61K	Sell	6,333 -20	-0.3%	-$8	﹤0.01%	4807
2024 Q3	$2.69K	Buy	6,353 +439	+7%	+$466	﹤0.01%	4949
2024 Q2	$8.1K	Sell	5,914 -96	-2%	-$131	﹤0.01%	4395
2024 Q1	$8.29K	Buy	6,010 +4,181	+229%	+$6.75K	﹤0.01%	4046
2023 Q4	$1.86K	Buy	+1,829	New	+$2.82K	﹤0.01%	5310

Other funds holding SYRA

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Tower Research Capital (TRC)'s SYRA Position: Q2 2025 in Review

Tower Research Capital (TRC) sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 6,344 shares — an estimated $1.65K sold.

Tower Research Capital (TRC) first reported a position in SYRA in Q4 2023 and held it in 6 quarters. The position peaked at $8.29K in Q1 2024. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

Tower Research Capital (TRC) reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 6,344 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $1.65K.
Tower Research Capital (TRC) first reported a position in Syra Health Corp. Class A Common Stock in Q4 2023 and held it in 6 quarters.
Tower Research Capital (TRC)'s Syra Health Corp. Class A Common Stock position peaked at $8.29K in Q1 2024.
2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.